Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $18.9B | $42B | $65.5B | $42.7B | $36.8B | |
| Revenue Growth (YoY) | -28.15% | 122.75% | 55.8% | -34.84% | -13.85% | |
| Cost of Revenues | $15.5B | $31.3B | $48.5B | $33.4B | $28.5B | |
| Gross Profit | $3.4B | $10.7B | $17B | $9.3B | $8.3B | |
| Gross Profit Margin | 17.95% | 25.52% | 25.94% | 21.78% | 22.46% | |
| R&D Expenses | $69.5M | $68.6M | $68.3M | $82.2M | $94.1M | |
| Selling, General & Admin | $2.2B | $3.2B | $2.8B | $3.2B | $3B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $2.7B | $4.1B | $5.1B | $4.4B | $3.9B | |
| Operating Income | $709.1M | $6.6B | $11.9B | $4.9B | $4.4B | |
| Net Interest Expenses | $230.3M | $261.2M | $248M | $266M | $268.3M | |
| EBT. Incl. Unusual Items | $954.2M | $5B | $10.4B | $4.6B | $4.3B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$687.4M | $2.4B | $5.9B | $2.9B | $2.4B | |
| Net Income to Company | $1.7B | $3.3B | $5.4B | $2.1B | $2.2B | |
| Minority Interest in Earnings | $155M | $729.3M | $1.5B | $395.7M | $617.6M | |
| Net Income to Common Excl Extra Items | $1.6B | $3.2B | $5.4B | $2B | $2.1B | |
| Basic EPS (Cont. Ops) | $1.10 | $1.89 | $2.92 | $1.22 | $1.15 | |
| Diluted EPS (Cont. Ops) | $1.10 | $1.89 | $2.92 | $1.22 | $1.15 | |
| Weighted Average Basic Share | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | |
| Weighted Average Diluted Share | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | |
| EBITDA | $3B | $9.6B | $14.7B | $7.7B | $7.2B | |
| EBIT | $709.1M | $6.6B | $11.9B | $4.9B | $4.4B | |
| Revenue (Reported) | $18.9B | $42B | $65.5B | $42.7B | $36.8B | |
| Operating Income (Reported) | $709.1M | $6.6B | $11.9B | $4.9B | $4.4B | |
| Operating Income (Adjusted) | $709.1M | $6.6B | $11.9B | $4.9B | $4.4B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $10B | $17.3B | $10.3B | $7.4B | $7.3B | |
| Revenue Growth (YoY) | 132.26% | 72.28% | -40.41% | -28.27% | -1% | |
| Cost of Revenues | $8B | $12.6B | $7.9B | $5.8B | $5.4B | |
| Gross Profit | $2B | $4.6B | $2.4B | $1.6B | $1.9B | |
| Gross Profit Margin | 19.83% | 26.83% | 23.53% | 21.95% | 25.91% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $788.6M | $846.7M | $818.1M | $781.1M | $567.9M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $951.2M | $1.3B | $1.1B | $728.3M | $745.5M | |
| Operating Income | $1B | $3.4B | $1.4B | $893.1M | $1.1B | |
| Net Interest Expenses | $115.5M | $103.7M | $124M | $101.1M | $107.5M | |
| EBT. Incl. Unusual Items | $1B | $3.2B | $1.3B | $776.7M | $1.2B | |
| Earnings of Discontinued Ops. | -- | -- | -- | $103.3M | $76M | |
| Income Tax Expense | $627.1M | $2B | $698.4M | $520.7M | $557.4M | |
| Net Income to Company | $567.9M | $1.3B | $744.8M | $466.8M | $844.9M | |
| Minority Interest in Earnings | $212.2M | $511.4M | $205.6M | $186.8M | $194M | |
| Net Income to Common Excl Extra Items | $541M | $1.4B | $721.2M | $348.2M | $752.5M | |
| Basic EPS (Cont. Ops) | $0.25 | $0.64 | $0.39 | $0.20 | $0.49 | |
| Diluted EPS (Cont. Ops) | $0.25 | $0.64 | $0.39 | $0.20 | $0.48 | |
| Weighted Average Basic Share | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | |
| Weighted Average Diluted Share | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | |
| EBITDA | $1.8B | $4B | $2.1B | $1.4B | $1.8B | |
| EBIT | $1B | $3.4B | $1.4B | $893.1M | $1.1B | |
| Revenue (Reported) | $10B | $17.3B | $10.3B | $7.4B | $7.3B | |
| Operating Income (Reported) | $1B | $3.4B | $1.4B | $893.1M | $1.1B | |
| Operating Income (Adjusted) | $1B | $3.4B | $1.4B | $893.1M | $1.1B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $32.4B | $66B | $46.6B | $32.1B | $29.6B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $25.5B | $48.9B | $37.4B | $24.4B | $22.9B | |
| Gross Profit | $7B | $17.1B | $9.2B | $7.7B | $6.7B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $3B | $3.1B | $2.9B | $3.2B | $2.4B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $3.5B | $4.9B | $4.1B | $3.2B | $3.2B | |
| Operating Income | $3.4B | $12.2B | $5.1B | $4.5B | $3.5B | |
| Net Interest Expenses | $383.3M | $423.3M | $442.7M | $417.2M | $448.6M | |
| EBT. Incl. Unusual Items | $5.1B | $10.5B | $5B | $4.1B | $3.8B | |
| Earnings of Discontinued Ops. | -- | -- | -- | $184.5M | $295M | |
| Income Tax Expense | $868.3M | $5.6B | $3.3B | $2.5B | $2.4B | |
| Net Income to Company | $4.8B | $5.8B | $2.1B | $2.1B | $2B | |
| Minority Interest in Earnings | $644.3M | $1.6B | $450.2M | $625.4M | $549M | |
| Net Income to Common Excl Extra Items | $4.8B | $5.7B | $2.1B | $1.9B | $1.6B | |
| Basic EPS (Cont. Ops) | $3.14 | $3.16 | $1.27 | $1.10 | $1.06 | |
| Diluted EPS (Cont. Ops) | $3.14 | $3.16 | $1.27 | $1.09 | $1.02 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $6.4B | $16.1B | $8B | $6.8B | $6.2B | |
| EBIT | $3.4B | $12.2B | $5.1B | $4.5B | $3.5B | |
| Revenue (Reported) | $32.4B | $66B | $46.6B | $32.1B | $29.6B | |
| Operating Income (Reported) | $3.4B | $12.2B | $5.1B | $4.5B | $3.5B | |
| Operating Income (Adjusted) | $3.4B | $12.2B | $5.1B | $4.5B | $3.5B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $26.5B | $50.8B | $31.8B | $21.3B | $20.4B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $20.4B | $36.6B | $25.1B | $16.1B | $15.3B | |
| Gross Profit | $6.1B | $14.2B | $6.8B | $5.2B | $5.1B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $2.4B | $2.3B | $2.4B | $2.3B | $1.7B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $2.8B | $3.7B | $3.2B | $2.1B | $2.3B | |
| Operating Income | $3.3B | $10.5B | $3.6B | $3.1B | $2.8B | |
| Net Interest Expenses | $299.9M | $328.4M | $333.6M | $303.2M | $324.9M | |
| EBT. Incl. Unusual Items | $3.4B | $8.8B | $3.4B | $2.9B | $2.8B | |
| Earnings of Discontinued Ops. | -- | -- | -- | $184.5M | $295M | |
| Income Tax Expense | $1.4B | $4.6B | $2.1B | $1.7B | $1.8B | |
| Net Income to Company | $2.5B | $5B | $1.7B | $1.8B | $1.6B | |
| Minority Interest in Earnings | $595.4M | $1.4B | $325.7M | $555.5M | $483.9M | |
| Net Income to Common Excl Extra Items | $2.5B | $4.9B | $1.7B | $1.6B | $1.2B | |
| Basic EPS (Cont. Ops) | $1.43 | $2.69 | $1.03 | $0.90 | $0.81 | |
| Diluted EPS (Cont. Ops) | $1.43 | $2.69 | $1.03 | $0.90 | $0.78 | |
| Weighted Average Basic Share | $3.9B | $3.9B | $3.9B | $3.9B | $3.9B | |
| Weighted Average Diluted Share | $3.9B | $3.9B | $3.9B | $3.9B | $4.5B | |
| EBITDA | $5.6B | $12.3B | $5.7B | $4.8B | $4.4B | |
| EBIT | $3.3B | $10.5B | $3.6B | $3.1B | $2.8B | |
| Revenue (Reported) | $26.5B | $50.8B | $31.8B | $21.3B | $20.4B | |
| Operating Income (Reported) | $3.3B | $10.5B | $3.6B | $3.1B | $2.8B | |
| Operating Income (Adjusted) | $3.3B | $10.5B | $3.6B | $3.1B | $2.8B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $3.5B | $5.8B | $8.7B | $7.9B | $6.5B | |
| Short Term Investments | $940.9M | $1.5B | $1.6B | $1.5B | $883.4M | |
| Accounts Receivable, Net | $2.3B | $4.5B | $4.5B | $3.8B | $2.9B | |
| Inventory | $2.9B | $3.6B | $5.2B | $3.9B | $4.1B | |
| Prepaid Expenses | $116.2M | $162.6M | $166.5M | $301.6M | $318.9M | |
| Other Current Assets | $174.7M | $210.6M | $1.1B | $923M | $1B | |
| Total Current Assets | $14.8B | $21.1B | $24.3B | $19.3B | $16.3B | |
| Property Plant And Equipment | $23.5B | $21.1B | $20.6B | $22.2B | $21.2B | |
| Long-Term Investments | $14.4B | $12.1B | $9.9B | $9.3B | $9.1B | |
| Goodwill | $653.1M | $636.3M | $627.4M | $424.5M | $531.7M | |
| Other Intangibles | $2B | $1.8B | $1.1B | $1.2B | $1.3B | |
| Other Long-Term Assets | $52.9M | $38.5M | $40.8M | $123.8M | $138.4M | |
| Total Assets | $63.4B | $64.6B | $63.8B | $58.4B | $52.5B | |
| Accounts Payable | $5.3B | $5.5B | $5.6B | $4.4B | $3.9B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $173.4M | $148.3M | $166.2M | $200.1M | $242.5M | |
| Other Current Liabilities | $202.9M | $320.4M | $363.5M | $310.6M | $388.1M | |
| Total Current Liabilities | $13B | $15.6B | $14.9B | $10.9B | $9.7B | |
| Long-Term Debt | $16.5B | $13.7B | $11.9B | $11.6B | $10.3B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $43B | $42.4B | $38B | $33.1B | $29B | |
| Common Stock | $400.1M | $371.9M | $349M | $361.2M | $338.6M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $12.9B | $14.8B | $17.8B | $17.4B | $16.4B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $7.5B | $7.4B | $8B | $7.9B | $7B | |
| Total Equity | $20.4B | $22.2B | $25.8B | $25.3B | $23.4B | |
| Total Liabilities and Equity | $63.4B | $64.6B | $63.8B | $58.4B | $52.5B | |
| Cash and Short Terms | $3.5B | $5.8B | $8.7B | $7.9B | $6.5B | |
| Total Debt | $18.4B | $14.9B | $13.6B | $12.7B | $11.8B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $4.7B | $7.5B | $8.2B | $6.5B | $5.2B | |
| Short Term Investments | $7.2B | $7.3B | $2.4B | $1.3B | -- | |
| Accounts Receivable, Net | $3.9B | $5.6B | $3.2B | $3B | $2.3B | |
| Inventory | $3.5B | $5.2B | $4.2B | $4.3B | $2.8B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $566M | $930.8M | $981.2M | $1.2B | -- | |
| Total Current Assets | $20B | $26.6B | $19.1B | $16.3B | $12.8B | |
| Property Plant And Equipment | $21.2B | $18.8B | $21.5B | $22.4B | $18.3B | |
| Long-Term Investments | $15B | $11.1B | $9.2B | $9B | $7.4B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $104.4M | $102.2M | $113.3M | $234.5M | -- | |
| Total Assets | $63.7B | $62.1B | $53.6B | $53.8B | $53.5B | |
| Accounts Payable | $4.3B | $5.9B | $4.4B | $3.8B | $3.4B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $156.6M | $146.5M | $169.4M | $224.5M | -- | |
| Other Current Liabilities | $1.5B | $1.6B | $1.6B | $1.7B | -- | |
| Total Current Liabilities | $17.1B | $17.5B | $11.1B | $9.5B | $7.8B | |
| Long-Term Debt | $14.8B | $11.5B | $11.1B | $11.3B | $10.1B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $42.1B | $37.4B | $29.2B | $29.1B | $29.3B | |
| Common Stock | $379M | $320.3M | $346.2M | $364.9M | $384.2M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $7.3B | $7.4B | $7.5B | $8B | $7.4B | |
| Total Equity | $21.6B | $24.7B | $24.4B | $24.7B | $24.2B | |
| Total Liabilities and Equity | $63.7B | $62.1B | $53.6B | $53.8B | $53.5B | |
| Cash and Short Terms | $4.7B | $7.5B | $8.2B | $6.5B | $5.2B | |
| Total Debt | $15B | $11.6B | $11.2B | $11.5B | $10.4B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.7B | $3.3B | $5.4B | $2.1B | $2.2B | |
| Depreciation & Amoritzation | $2.2B | $2.8B | $2.6B | $2.6B | $2.6B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $165.3M | -$2.3B | -$417.2M | $1.1B | $788.6M | |
| Change in Inventories | $328.3M | -$1.3B | -$2.3B | $1.4B | -$77.9M | |
| Cash From Operations | $3.6B | $8.3B | $8.2B | $6.2B | $5.9B | |
| Capital Expenditures | $2.2B | $3B | $3.1B | $3.8B | $3.8B | |
| Cash Acquisitions | $4.4B | $4.7M | $226M | $57.3M | $215.3M | |
| Cash From Investing | -$6.8B | -$2.2B | -$2B | -$3.3B | -$3.4B | |
| Dividends Paid (Ex Special Dividend) | $767.2M | $866.4M | $890.2M | $1.9B | $1.9B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $3.8B | $295.8M | -- | -- | $1.1B | |
| Long-Term Debt Repaid | -$910.2M | -$2.7B | -$1.1B | -$1.6B | -$1.1B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $1.4B | -$3.5M | $31.6M | -$1.1M | -$542.3M | |
| Cash From Financing | $3.2B | -$3.5B | -$2.8B | -$4.1B | -$3.4B | |
| Beginning Cash (CF) | $3.5B | $5.7B | $8.6B | $7.6B | $6.4B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$78.7M | $2.6B | $3.2B | -$1.2B | -$895.6M | |
| Ending Cash (CF) | $3.3B | $8.3B | $11.8B | $6.4B | $5.5B | |
| Levered Free Cash Flow | $1.3B | $5.3B | $5.1B | $2.4B | $2.1B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $567.9M | $1.3B | $744.8M | $466.8M | $844.9M | |
| Depreciation & Amoritzation | $821.9M | $680.9M | $720.4M | $688.4M | $669.4M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $496M | -$222.9M | -$449.3M | $230.1M | -$49.4M | |
| Change in Inventories | -$528.8M | -$231.1M | $23.7M | -$41.3M | -$467.3M | |
| Cash From Operations | $1.9B | $3.3B | $1.9B | $1.5B | $1.3B | |
| Capital Expenditures | $685.1M | $742.7M | $943.9M | $965.5M | $1.1B | |
| Cash Acquisitions | $4.8M | -$2.2M | $34.2K | $150.8M | $434.7K | |
| Cash From Investing | -$713M | -$949.9M | -$280.6M | -$1.3B | -$1.2B | |
| Dividends Paid (Ex Special Dividend) | -$287.5M | $666.5M | $405.9M | $41.4M | $133.5M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | $553.3K | |
| Other Financing Activities | -$4.7M | -$1M | -$1.1M | -$11.5M | -- | |
| Cash From Financing | -$58.3M | -$1.2B | -$132.7M | $272.6M | -$1.7B | |
| Beginning Cash (CF) | $4.7B | $7.5B | $8.2B | $6.5B | $5.2B | |
| Foreign Exchange Rate Adjustment | -$4.7M | $7.2M | -$4.4M | -$8.7M | -$5.1M | |
| Additions / Reductions | $1.1B | $1.1B | $1.4B | $530.9M | -$1.5B | |
| Ending Cash (CF) | $5.8B | $8.6B | $9.7B | $7B | $3.7B | |
| Levered Free Cash Flow | $1.2B | $2.5B | $923.5M | $584.5M | $204.9M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $4.8B | $5.8B | $2.1B | $2.1B | $2B | |
| Depreciation & Amoritzation | $1.7B | $4.2B | $2.8B | $2.8B | $3B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$1.4B | -$3.5B | $3.1B | $379.5M | -$311M | |
| Change in Inventories | -$1B | -$2.7B | $1.2B | $268M | $166.3M | |
| Cash From Operations | $5.9B | $10B | $6.4B | $5.9B | $5.1B | |
| Capital Expenditures | $2.8B | $3B | $3.7B | $3.7B | $4.3B | |
| Cash Acquisitions | $4.4B | $228.8M | $4M | $253M | $24M | |
| Cash From Investing | -$6.8B | -$1.6B | -$3.1B | -$4.1B | -$2.6B | |
| Dividends Paid (Ex Special Dividend) | $1.3B | $1.9B | $1.5B | $2.2B | $1.9B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | $15.8M | |
| Other Financing Activities | -$38.7M | $159.3K | -- | -- | -- | |
| Cash From Financing | -$2.7B | -$4.4B | -$3.2B | -$3.9B | -$3.9B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$3.5B | $3.9B | $71.8M | -$2B | -$1.5B | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $3.1B | $6.9B | $2.7B | $2.2B | $800.7M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2.5B | $5B | $1.7B | $1.8B | $1.6B | |
| Depreciation & Amoritzation | $2.4B | $1.9B | $2.1B | $2.2B | $1.8B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$597.4M | -$1.8B | $1.8B | $1B | -$74.4M | |
| Change in Inventories | -$996.1M | -$2.4B | $1.1B | -$83.4M | $161.1M | |
| Cash From Operations | $5.1B | $6.7B | $5B | $4.8B | $4B | |
| Capital Expenditures | $2.1B | $2.2B | $2.8B | $2.7B | $3.2B | |
| Cash Acquisitions | $4.8M | $228.9M | $8.7M | $204.8M | $12.4M | |
| Cash From Investing | -$1.6B | -$1.1B | -$2.2B | -$3B | -$2.2B | |
| Dividends Paid (Ex Special Dividend) | $777M | $1.5B | $2.1B | $1.8B | $1.8B | |
| Special Dividend Paid | -- | -- | $604.3K | $562.4K | $484.9K | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -$94.7M | |
| Repurchase of Common Stock | -- | -- | -- | -- | $15.8M | |
| Other Financing Activities | -$4.7M | -$1M | -$1.1M | -$549.9M | $843.7M | |
| Cash From Financing | -$2B | -$2.8B | -$3.2B | -$3B | -$3.5B | |
| Beginning Cash (CF) | $12.4B | $21B | $25.3B | $20.6B | $17.5B | |
| Foreign Exchange Rate Adjustment | -$18M | -$58.6M | -$20.7M | -$8.7M | -$51.8M | |
| Additions / Reductions | $1.4B | $2.8B | -$362.3M | -$1.2B | -$1.8B | |
| Ending Cash (CF) | $13.8B | $23.7B | $25B | $19.4B | $15.7B | |
| Levered Free Cash Flow | $3B | $4.6B | $2.3B | $2.1B | $789.9M | |
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.